Journal
CANCER BIOLOGY & THERAPY
Volume 7, Issue 1, Pages 3-9Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.7.1.5163
Keywords
breast cancer; bone metastasis; osteoclasts; osteoblasts; TGF beta; RANKL; PTH-rP; IL-11
Categories
Funding
- NATIONAL CANCER INSTITUTE [R21CA112588, R01CA127380] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Breast carcinoma ranks among the most prevalent malignancies in women. Breast carcinoma frequently metastasizes to bone and approximately 70% of patients with breast cancer have bone metastases, which generally are osteolytic lesions. They cause major morbidity and mortality in patients; and the available treatment options are limited. Bone-specific homing and colonization of cancer cells are important and interesting features of metastasis. There are complex and multiple steps in the process of bone metastasis; and the elaborate interaction between breast carcinoma and bone involves various cytokines, growth factors and cellular signals, which results in a vicious cycle and promotes tumor cell accumulation and osteolysis. Recent advances in molecular biology have resulted in major breakthroughs in our understanding of the pathogenesis of bone metastasis in breast cancer, which is critical in preventing metastasis, designing novel and targeted treatments and prolonging survival in this devastating condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available